Organ Preservation: Weekly Carboplatin and Taxol [paclitaxel] w/ Concurrent RT [radiotherapy] for Locally Advanced Laryngeal and Hypopharyngeal CA [head and neck cancer]
Phase of Trial: Phase III
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 04 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2011 Planned End Date 1 Sep 2015 added as reported by ClinicalTrials.gov.
- 11 Dec 2011 Planned number of patients 200 added as reported by ClinicalTrials.gov.